Bimekizumab
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Bimekizumab and local guidelines before prescribing.
Biologic (IL-17)
Mechanism
IL-17A and IL-17F monoclonal antibody.
Uses
Plaque psoriasis, psoriatic arthritis, axial spondyloarthritis.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Candidiasis, upper respiratory infection, IBD flares.
Interactions
Live vaccines contraindicated.
Contraindications and cautions
Active infection, IBD
Monitoring
TB screen
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
No adjustment
Overdose and reversal
Supportive
Special advice
Screen for TB.
More from the textbook: uses, cautions and other points
- IL-17 inhibitors (secukinumab, ixekizumab, bimekizumab) - good if psoriasis; avoid with IBD.
Rheumatology: Inflammatory arthritis - IL-17 inhibitors - secukinumab, ixekizumab, brodalumab, bimekizumab (also IL-17F).
Dermatology: Skin basics, eczema and psoriasis - IL-17 | Secukinumab, ixekizumab, bimekizumab | Psoriatic arthritis, axial SpA
Rheumatology Anatomy Physiology Pharmacology - IL-17 | Secukinumab, ixekizumab, bimekizumab | Psoriatic arthritis, axial SpA , psoriasis | Worsening or new IBD , candida infections
Rheumatology: assessment, investigations and drugs - IL-17A | Secukinumab, ixekizumab, bimekizumab (IL-17A/F) | Psoriasis, psoriatic arthritis, axial SpA | Candidiasis ; may trigger or worsen IBD
Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology
Where it is discussed in the book
- Dermatology: Skin basics, eczema and psoriasis (1 mention)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: assessment, investigations and drugs (1 mention)
- Rheumatology: Inflammatory arthritis (1 mention)
- Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology (1 mention)